PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS S.A. (STNT.PA), a medical technology company that is commercializing a new generation of innovative stents to treat acute myocardial infarction (AMI), announced today the launch of the STENTYS stents in four additional European countries: Scandinavia, Spain, Switzerland and Poland.
